Concurrent Inhibition of AKT and GLUT1 Reveals Endpoint-Specific Effects on Glucose Metabolism and Cell Death in HepG2 Hepatocyte-Derived Cells.
- DOI
- 10.3390/biomedicines14092133
- Published
- 2026 Sep 21
- Container
- Biomedicines
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/biomedicines14092133,
title = {Concurrent Inhibition of AKT and GLUT1 Reveals Endpoint-Specific Effects on Glucose Metabolism and Cell Death in HepG2 Hepatocyte-Derived Cells.},
author = {Asiri A and Otaibi AA and Tasleem M and Al Shaikh Mubarak S and Said MA and Mihmadi YA and Subei BA and Asiri A and Qarni AA and Bakillah A},
year = {2026},
journal = {Biomedicines},
doi = {10.3390/biomedicines14092133},
url = {https://doi.org/10.3390/biomedicines14092133}
}RIS
TY - JOUR TI - Concurrent Inhibition of AKT and GLUT1 Reveals Endpoint-Specific Effects on Glucose Metabolism and Cell Death in HepG2 Hepatocyte-Derived Cells. AU - Asiri A AU - Otaibi AA AU - Tasleem M AU - Al Shaikh Mubarak S AU - Said MA AU - Mihmadi YA AU - Subei BA AU - Asiri A AU - Qarni AA AU - Bakillah A PY - 2026 JO - Biomedicines DO - 10.3390/biomedicines14092133 UR - https://doi.org/10.3390/biomedicines14092133 ER -
APA
A, A., AA, O., M, T., S, A. S. M., MA, S., YA, M., BA, S., A, A., AA, Q., & A, B. (2026). Concurrent Inhibition of AKT and GLUT1 Reveals Endpoint-Specific Effects on Glucose Metabolism and Cell Death in HepG2 Hepatocyte-Derived Cells.. Biomedicines. https://doi.org/10.3390/biomedicines14092133
Source records
- pubmed · retrieved 2026-09-26T21:24:49.738Z